22nd Century Return on Investment 2011-2024 | XXII

Current and historical return on investment (ROI) values for 22nd Century (XXII) over the last 10 years.
22nd Century ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-09-30 $-0.02B $0.01B -836.36%
2024-06-30 $-0.03B $0.01B -700.00%
2024-03-31 $-0.04B $-0.00B -153.54%
2023-12-31 $-0.04B $0.00B -88.00%
2023-09-30 $-0.03B $0.01B -60.00%
2023-06-30 $-0.04B $0.09B -48.21%
2023-03-31 $-0.04B $0.10B -43.89%
2022-12-31 $-0.03B -59.73%
2022-09-30 $-0.04B $0.12B -76.02%
2022-06-30 $-0.04B $0.10B -140.00%
2022-03-31 $-0.03B inf%
2021-12-31 $-0.03B inf%
2021-09-30 $-0.03B inf%
2021-06-30 $-0.02B -176.00%
2021-03-31 $-0.02B -76.92%
2020-12-31 $-0.02B -46.63%
2020-09-30 $-0.02B $0.05B -33.78%
2020-06-30 $-0.02B $0.05B -39.83%
2020-03-31 $-0.02B $0.06B -38.33%
2019-12-31 $-0.02B $0.06B -38.10%
2019-09-30 $-0.02B $0.06B -36.64%
2019-06-30 $-0.02B $0.06B -30.77%
2019-03-31 $-0.02B $0.07B -32.43%
2018-12-31 $-0.02B $0.07B -42.67%
2018-09-30 $-0.02B $0.08B -57.52%
2018-06-30 $-0.02B $0.07B -104.11%
2018-03-31 $-0.02B inf%
2017-12-31 $-0.01B inf%
2017-09-30 $-0.01B inf%
2017-06-30 $-0.01B -300.00%
2017-03-31 $-0.01B -160.00%
2016-12-31 $-0.01B -102.13%
2016-09-30 $-0.01B $0.02B -81.36%
2016-06-30 $-0.01B $0.01B -82.76%
2016-03-31 $-0.01B $0.02B -72.13%
2015-12-31 $-0.01B $0.01B -84.21%
2015-09-30 $-0.02B $0.02B -98.36%
2015-06-30 $-0.02B $0.02B -130.43%
2015-03-31 $-0.02B $0.01B -206.90%
2014-12-31 $-0.01B $0.02B -300.00%
2014-09-30 $0.00B nan%
2014-06-30 $0.00B inf%
2014-03-31 $0.00B -114.29%
2013-12-31 $0.00B -53.33%
2013-09-30 $-0.01B 133.33%
2013-06-30 $-0.01B $-0.01B 117.65%
2013-03-31 $-0.00B $-0.01B 133.33%
2012-12-31 $-0.00B 171.43%
2012-09-30 $-0.00B $-0.00B 150.00%
2012-06-30 $-0.00B $-0.00B 133.33%
2012-03-31 $-0.00B $-0.00B 133.33%
2011-12-31 $-0.00B $-0.00B 228.57%
Sector Industry Market Cap Revenue
Consumer Staples Tobacco Products $0.005B $0.032B
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
Stock Name Country Market Cap PE Ratio
Philip Morris (PM) United States $201.413B 20.37
Altria (MO) United States $94.672B 11.13
British American Tobacco (BTI) United Kingdom $76.797B 0.00
Imperial Tobacco Group (IMBBY) United Kingdom $26.636B 0.00
Universal (UVV) United States $1.356B 10.62
Turning Point Brands (TPB) United States $1.080B 20.76